BME100 s2014:W Group1 L1

BME 100 Fall 2013	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: David Kish Name: Khalid Al-Qahtani Name: Danielle Eldred Name: Maria Jose Quezada Valladares Name: John Tobey LAB 1 WRITE-UP Independent and Dependent Variables Independent Variable: lipopolysaccharide dosage (mg) This variable is the one that is being modified throughout the experiment. Dependent Variable: Inflammotin (units) Inflammotin in each patient will be the variable that varies according to the dosage implemented for their certain variable group. Experimental Design Groups a. 22 Groups b. 2 Control i) Each control group will be tested to see the natural measurements of Inflammotin. c. Variable i) We will have twenty variable groups, one of each gender ii) each gender group will be subject to .5 mg doses iii) each gender group will be subject to 1 mg doses iv) each gender group will be subject to 1.5 mg doses v) each gender group will be subject to 2 mg doses vi) each gender group will be subject to 2.5 mg doses vii) each gender group will be subject to 3 mg doses viii) each gender group will be subject to 3.5 mg doses ix) each gender group will be subject to 4 mg doses x) each gender group will be subject to 4.5 mg doses xi) each gender group will be subject to 5 mg doses xii) each gender group will be subject to 5.5 mg doses xiii) each gender group will be subject to 6 mg doses xiv) each gender group will be subject to 6.5 mg doses xv) each gender group will be subject to 7 mg doses xvi) each gender group will be subject to 7.5 mg doses xvii) each gender group will be subject to 8 mg doses xviii) each gender group will be subject to 8.5 mg doses xix) each gender group will be subject to 9 mg doses xx) each gender group will be subject to 9.5 mg doses xxi) each gender group will be subject to 10mg doses This was done to test half doses, three-quarter doses, and full doses to monitor efficiency to properly execute the experiment while also being fiscally responsible. Age a. 50+ We want a diverse age group to be tested therefore restrictions would inhibit our ability to get a proper measurement. Number of subjects per group a.10 people per group Subject Selection The criterion regarding the selection of test subjects are as follows. a)No test subject will be below the age of fifty. b)There will be two distinct groups of test subjects that are segregated by gender. Based on the stated criterion a random selection will be implemented to avoid bias from swaying the integrity of the experiment. Control will be established after the subjects are selected by deciding which people are placed at which dosage. Sources of Error and Bias 1)Age. We chose a broad age group that also had a broad exclusion. All those under the age of fifty are not being tested therefor we do not know efficiency in that age group, while having a broad range above fifty means that distinct effects within certain sections of our test subject will be neglected. 2)Ethnicity. Genetics play a primary role in how our body reacts therefor differing ethnicity may have different reactions. Without ensuring ethnic diversity we may neglect a certain culture within the experiment. 3)Life style. Certain people may exercise more or have a better diet meaning their body may react differently than someone who refuses to exercise and has a poor diet. Control 1) Age. We could create more specific groupings based on age to ensure we know the effects and efficiency of lipopolysaccharide within each specific age group. 2)Ethnicity. With the randomization we could create sub classifications within the observed data to give proper attention to ethnic differences. 3) Life style cannot be controlled. Instead we will simply factor it in as a variable that will change how the drug works within our uncontrolled society.